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SUMMARY 
Synthetic luteinizing hormone-releasing hormone (LH-RH) lost both its immunore- 
activity and hormonal activity on incubation with hypothalamic or cerebrocortical slices 
or homogenates. This inactivation was shown to be due to degradation of the decapep- 
tide by soluble enzyme(s) present in the 100,000 x g supernatant fraction of the homo- 
genates. The supernatant derived from one rat hypothalamus was capable of destroying 
1 /.L g of exogenous LH-RH within 5 min. The hexapeptide pGlu-His-Trp-Ser-Tyr-Gly 
was identified as the major radioactive breakdown product of [ pGl~-3-~H] LH-RH, and 
tentative evidence for the formation of the tetrapeptide Leu-Arg-Pro-Gly-NH2 was ob- 
tained by sequential electrophoresis and paper chromatography. These findings suggest 
that the Gly-Leu bond may be the preferred site of cleavage. 
A decapeptide has been isolated from the hypothalamus of several mammalian 
species, which stimulates the secretion of gonadotropic hormones from the pituitary 
gland in vivo and in vitro , and its synthesis has been accomplished (1,2). Although -- 
designated %.tteinizing hormone-releasing hormone” (LH-RH), the use of specific 
antibodies generated against the synthetic peptide (3) established that it has a physio- 
logical role in regulating the secretion of follicle-stimulating hormone (FSH) as well 
as luteiniztng hormone (LB) (4). The mechanisms regulating hypothalamic LH-RH syn- 
thesis and release are not fully understood. Studies aimed at their elucidation employ 
both in vivo and in vitro systems; the latter commonly involve the incubation of hypo- - - 
thalamic fragments and the determination of LH-RH by either biological or immuno- 
logical assays. Hypothalamic and other cerebral tissues, however, have been shown to 
contain peptidases (5), that may seriously interfere with such studies. 
We wish to report the existence of enzymic activity, in the soluble fraction of hypo- 
thalamic and cerebrocortical extracts, which causes structural alteration of the LH-RH 
molecule, resulting in loss of both its immunological properties and biological activity. 
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MATERIALS AND METHODS 
Materials. LH-RH was a generous gift of Hoechst A. G. (Frankfurt). 
[ Pyroglutamyl-3-3H]LH-RH was purchased from New England Nuclear (Boston). The 
following proteinsase inhibitors were used: Kallikrein inactivator (Trasylol; SK/T22/3, 
5100 KIU/mg and GOS 746/31, 5700 KN/mg,Bayer A. G. , Frankfurt); soybean trypain 
inhibitor (Worthington Biochemical Corp., N. J. ); benzamidine (Eastman Kodak Co., 
Rochester) and L-1-tosylamide-2-phenyl-ethylchloromethyl ketone (TPCK, Sigma 
Chemical Co., St. Louis). 
Animals and tissue preparation. Two- to four-month-old male and female Wistar- 
derived rats of the Departmental colony were used. The animala were kilbd by decapi- 
tation, and hypothalami and slices of cerebral cortex were excised Immediately. Hypo- 
thalamic tissue from five animals (about 150 mg) or an equivalent weight of cortical 
tissue was homogenized in 1 ml 0.01 M phosphate-buffered saline (PBS), pH 6.9, by 
applying seven strokes in a Thomas teflon homogenizer immersed in crushed ice. The 
supematant fraction, collected after 30 min centrifugatlon at 17,000 x g or 100,000 x g 
at 4OC, was uaed. 
Incubation and extraction. Portions of the superuatant fractions were incubated in 
the presence of 1 pg LH-RH in 1 ml PBS at 37’C in a Dubnoff shaking bath. Incubations 
were terminated by boiling for 3 min; control experiments indicated that LH-RH is not 
damaged by this treatment. The samples were then spun for 30 min at 17,000 x g and 
the supernatant fraction was taken for determination of LH-RH by radioimmunoaesay 
(3) or biological assay. For electrophoresis and amino-acid analysis the supernatant 
fractioqderived from 105 mg wet brain tissue (equivalent to 3.5 hypothalami),was in- 
cubated for 10 min with 0.4 p Ci [ 3H] LH-RH diluted with 1 mg of the unlabeled hormone. 
After terminating the reaction by boiling, the samples (1 ml) were spun for 50 min at 
100,000 x g, filtered through a Disflo UM2 membrane (Amicon Corp., Lexington), 
lyophilized and redissolved in 0.2 ml distilled water. 
Assay of LH-releasing activity was performed according to Ramirez and McCann 
(6), using ovariectomized estrogen- and progesterone-primed rats. LH was determined 
by radioimmunoassay (7). 
Electrophoreeis was carried out on Whatman No. 3 paper @rewashed with 5% 
acetic acid) in pyridine acetate buffer, pH 3.5. for 10 min at 10 V/cm, followed by 
90 min at 60 V/cm. The region of this electropherogram carrying a slow-moving 
peak (Fig. la; Peak II) was excised, the segment sewn onto another strip of Whatman 
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Fig. 1. Electropherogram of the degradation products of LH- 
No. 2 paper and subjected to further high voltage electrophoresis (60 V/cm for 45 min 
in 2.596 formic acid and 7.5% acetic acid, pH 1.9). 
Amino-acid analysis. The radioactive and fluorescent electrophoretic components 
were eluted with 10% acetic acid, lyophilized, subjected to exhaustive hydrolysis 
(6N HCl, 18h, 11O’C) and to amino-acid analysis according to Spa&man et al. (8). 
RESULTS 
Enzymatic inactivation of LH-FlH. Incubation of LH-RH with the 17,000 x g or the 
100,000 x g supsmatant fraction of homogenates from rat hypothalamus or cerebral 
cortex resulted in progressive loss of the immunoreactivity and hormonal activity of 
the decapeptide. 
The velocity of LH-RH inactivation was assessed by exposing 1.2 ~1 g of the peptide 
to the supematant fraction,derived from one hypothalamus,for various periods. As 
shown in Table 1, less than 20% of the LH-RH added was measurable by radioimmuno- 
assay after 5 min incubation; after 15 min less than 1% of the intact decapeptide was 
recoverable. Inactivation of LH-RH was proportional to the amount of enzyme prepara- 
tion used (Table 2). Inactivation was temperature-dependent in that the supernatant 
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Table 1. Time course of LH-RH inactivation 
Incubation Time (minutes) LH-RH Recovered 
(ng f SEM, N=‘7) 
0 1200 f 28.8 
5 248 f 37.0 
10 15.3 * 5.2 
15 7.0-I 1.0 
30 4.3* 0.8 
60 1.8 f 0.5 
120 undetectable 
LH-RH (1.2 pg) was incubated with the supernatant fraction of one hypo- 
thalamus. The reaction was terminated by boiling and LH-RH-determined 
by radioimmunoassay. 
Table 2. Recovery of LH-RH after exposure to varying amounts of enzyme preparation 
Amount of tissue homogenized 
wet weight Equivalents of 
(mg) Hypothalamus 
LH-RH recovered after incubation with: 
Hypothalamus Cortex 
(%*s.E.M.) (‘% f S.E.M.) 
0 0 100 
0.3 0.01 net determined 
0.6 0.02 64.7 ZIZ 12.86 
1.5 0.05 16.4 l 1.72 
3.0 0.1 5.4 f 0.46 
6.0 0.2 0.4 f 0.05 
30 1 <o. 01 
100 
85.7 *1.58 
‘70.0 f 16.45 
not determined 
11.7 f 0.95 
0.7 f 0.05 
(0. 01 
LH-RH (1 pg) was incubated for 1 h with sequential dilutions of the supernatant fraction 
of homogenates from one rat hypothalamus (30 mg wet weight) or an equivalent amount 
of cerebral cortex. The reaction was stopped by boiling and LH-RH determined by radio- 
immunoassay. N = 6. 
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fraction from 0.05 hypothalami destroyed 83% of the LH-RH (1 pg) during 1 h incuba- 
tion at 37’C, whereas at 2*C! only 31% of the LH-RH was lost. 
The effect of the enzyme-treated LH-RH on serum LH levels in ovariectomized, 
estrogen- and progesterone-treated rats was compared to that of the Intact hormone. 
As shown in Figure 2, the LH-releasing activity of LH-RH (1 pg) disappeared after 1 h 
incubation with the supernatant fraction from 6 mg of hypothalamic tissue. 
Inhibitors of LH-RH degradation. Several proteinase inhibitors were assayed for 
their ability to prevent the degradation of LH-RH by slices or homogenates of cerebral 
tissue. As shown in Table 3, Kallikrein inactivator (K. I. ),at high concentrations 
(0.2-l n&ml), prevented the enzymic inactivation of LH-RH as measured by radio- 
immunoassay, whereas a more purified preparation of this inhibitor (GOS 746/31) 
as well as soybean trypsin inhibitor, TPCK and benzamldine were ineffective. 
K. I. (SK/T22/3) also prevented loss of the LH-releasing activity of LH-RH during 1 h 
incubation with the supernatant from 6 mg of hypothalamic tissue (Fig. 2). 
Identification of degradation products by electrophoresis, chromatography and 
amino-acid analysis. Tritiated LH-RH was incubated for 10 min with the hypothalamic 
supernatant preparation. Electrophoresis of an aliquot of the incubation products at 
CONTROL 5qLti-Fa 25ngLH-i?H z!hgLt+Fui ZslgLHRH 
ENZYME ENZYME’KI 
TREATED TREATED 
Fig. 2. Effect of enzyme treatment on the biological activity of LH-RH. Groups of five 
ovariectomized estrogen- and progesterone-primed rats, were injected intravenously 
with: saline (control); LH-RH (5 or 25 ng); LH-RH (25 ng portions of 1 pg) with the 
enzyme preparation in the presence or absence of Kallikrein inactivator (K. I. ). Blood 
samples were collected, by heart puncture, 15 min later and LH was measured by 
radioimmunoassay. Results are expressed in terms of NUMD-Rat LH-RP-1. 
Vertical bars represent standard errors of the mean. 
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Table 3. Effect of proteinase inhibitors on LH-RH inactivation 
Recovery of immunoreactive LH-RI-I from 
the incubation medium of: 
Inhibitor 
Kallikrein-inactivator 2 p g/ml 
Kallikrein-inactivator 200 p g/ml 
Kallikrein-inactivator 1 mg/ml 
Soybean trypsin inhibitor 1 mg/ml 
Benzamidine 15 mg/ml 
TPCK 3 p g/ml 
Excised 
Hypothalamus 
42.5 f 4.98+ 
53.7 f 2.92 
92.0 f 1.74 
52.8 f 0.72 
Homogenized 
Hypothalamus 
0 
33.1 f 2.10 
99.3 f 0.68 
0.8 l 0.11 
0.4 f 0.14 
*%*S.E.M.; N=l4 
LH-RH (1 pg) was incubated for 1 h with one hypothalamus or with the supernatant 
fraction of one homogenized hypothalamus. Where indicated, inhibitors were added 
to the incubation medium. The reaction was stopped by boiling and LH-RH determined 
by radioimmunoassay. 
pH 3.5 revealed two radioactive peaks (Fig. la). One of these (I) corresponded to the 
authentic LH-RH marker. The slower-moving peak (II) was eluted, hydrolyzed and 
subjected to amino-acid analysis. It was found to contain all the amino acids of LH-RH, 
except for a&nine, in the molar ratios present in the native hormone. The absence of 
arginine in this electrophoretlc fraction was confirmed by a negative Sakaguchi’s test. 
Under these conditions of electrophoresis, however, free proline, leucine and glycine 
comigrate with the slow radioactive peak (II), and free arginine leaves the paper. Peak 
II was therefore subjected to further electrophoresis at pH 1.9. In this system, the 
material was resolved into three radioactive peaks, all of which were fluorescent, 
indicating the presence of tryptophan (Fig. lb). These peaks were eluted and subjected 
to hydrolysis and amino-acid analysis. The slowest component (Bc) contained glutamic 
acid, histidine, serlne, tyroslne and glycine in the apparent molar ratio of 1.0 : 
0. ‘7 : 0.7 : 0.4 : 1.1. In addition, the presence of tryptophan ln this peptlde was estab- 
lished by using p-toluenesulfonic acid, instead of hydrochloric acid, for hydrolysis. 
The second component (IIb} had the same ammo-acid composition, and its higher mobi- 
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Jity might be due to opening of the pyro-glutamic ring. The third Component (Ra) con- 
tained glutamic acid, histidine and serine (1.0 : 0.7 : 1. 0), and its fluorescence in- 
dicated the presence of tryptophan. 
Another portion of the incubation products was subjected to two-dimensional separa- 
tion by sequential electrophoresis and chromatography, alongside the following marker 
substances : Gly-NH2; Gly; Pro; Arg; Leu; Pro-Gly; Arg-Pro-Gly-NH2; 
Arg-Pro-Gly; Leu-Arg-Pro-Gly-NH2 and Leu-Arg-Pro-Gly. Electrophoresis was 
done at pH 1.9 (15 min at 10 V/cm and 30 mm at 60 V/cm). Chromatography was done 
on Whatman No. 3 paper in the system: n-butanol/acetic acid/water/pyridine (15:3: 
12:lO; v/v) at room temperature for 15 h. Components containing free amine groups 
were detected by use of the ninhydrin-cadmium reagent. The ninhydrin-reactive pro- 
ducts that corresponded in mobility to one of the marker substances were in the posi- 
tions occupied by Leu-Arg-Pro-Gly-NH2 and the free amino acids leucine and 
possibly arginine (trace). Several other ninhydrin-reactive components were present, 
but could not be identified. 
DISCUSSION 
Inactivation by brain tissue of several oligopeptide hormones, such as oxytocin (5) 
and thyrotropin-releasing hormone (9), has been attributed to enzymic degradation. Tn 
the case of oxytocin, one of the resulting fragments, claimed tc possess hormonal 
activity of its own, was in turn destroyed by an aminopeptidase (10, 11). LH-RR was 
shown to be inactivated by homogenates from liver and kidney (12), pituitary gland 
(Koch & Baram, unpublished) and hypothalamic extracts (13), but the nature of this 
inactivation has not been elucidated. 
In this study, the presence of potent LH-RH-inactivating enzyme(s) in rat hypotha- 
lamus and cerebral cortex was demonstrated. The enzymic activity responsible was 
associated with the 100,000 x g supernatant fraction of the homogenates, and passed 
into the medium during incubation of hypothalamic or cortical slices. Analysis of the 
incubation products suggested that the inactivation of LH-RH was due to cleavage of 
the Gly-Leu bond. This interpretation is supported by (1) identification of a radfo- 
active and fluorescent hexapeptide, pGlu-His-Trp-Ser-Tyr-Gly by electrophoresis in 
two different systems and amino acid analysis, as the major breakdown product of 
[ pyroglutamyl-3-3H] LH-RH;. (ii) tentative identification of the tetrapeptide Leu-Arg- 
Pro-Gly-NH2 by sequential electrophoresis and paper chromatography alongside a 
synthetic marker; (iii) failure tc detect any of the di- or tripeptides, or free amino 
acids other than leucine and possibly arginine, that would be formed if degradation 
101 
VoL61,No. 1, 1974 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
were due to the action of an exopeptidase attacking the C-terminal of the peptide. It 
would be desirable to confirm the identification of the tetrapeptide as a degradation 
product by use of LH-RH labeled near the C-terminal. 
The use of several proteinase inhibitors indicated that the degrading activity is not 
trypsin- or chymotrypsin-like. Sufficient activity was present in the supernatant frac- 
tion from a single rat hypothalamus to destroy 1 pg exogenous LH-RH within 5 min. 
The LH-RH content of the hypothalamus of a normal mature female rat is about 5 ng. 
Prima facie, these findings could suggest a very high turnover rate of LH-RH in the 
hypothalamus. However, it appears that endogenous LH-RH,stored in the neural tissue, 
is in some way protected from degradation (Koch & Baram, unpublished). While the 
physiological significance of this degradative pathway of LH-RH in the hypothalamus 
thus remains uncertain, its existence cannot be ignored when interpreting the results 
of in vitro experiments. A varying extent of LH-RH degradation under different in - 
vitro conditions may help explain the inconsistent results obtained in studies of the 
effects of neurotransmitters on LH and FSH release by pituitaries co-incubated with 
hypothalamic tissue (14, 15, 16, 1’7). 
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